Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma

Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma

MAPK signaling pathway-based glioma subtypes, machine-learning risk model, and key hub proteins identification

An expression based REST signature predicts patient survival and

Expression of the repressor element 1 silencing transcription

IJMS, Free Full-Text

The overexpression and clinical significance of TBX15 in human

Altered transcriptional regulatory proteins in glioblastoma and

A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer - Computational and Structural Biotechnology Journal

REST was significantly up-regulated in glioma. (A) The difference

Machine learning-based investigation of regulated cell death for predicting prognosis and immunotherapy response in glioma patients

Frontiers Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies